Edition:
United Kingdom

Galapagos NV (GLPG.AS)

GLPG.AS on Amsterdam Stock Exchange

101.70EUR
18 Apr 2019
Change (% chg)

€0.00 (+0.00%)
Prev Close
€101.70
Open
€100.85
Day's High
€102.70
Day's Low
€99.20
Volume
495,328
Avg. Vol
488,991
52-wk High
€111.80
52-wk Low
€70.64

About

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and... (more)

Overall

Beta: 1.05
Market Cap(Mil.): €4,412.26
Shares Outstanding(Mil.): 50.87
Dividend: --
Yield (%): --

Financials

  GLPG.AS Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.58 -- --
ROI: -2.51 8.91 13.83
ROE: -3.05 10.06 15.25

Shares in Galapagos jump 15 percent after arthritis drug results

AMSTERDAM Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib.

29 Mar 2019

Shares in Galapagos jump 15 pct after arthritis drug results

AMSTERDAM, March 29 Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib.

29 Mar 2019

BRIEF-Galapagos Increases Share Capital Through Warrant Exercises

* ANNOUNCED ON WEDNESDAY SHARE CAPITAL INCREASE THROUGH WARRANT EXERCISES

21 Mar 2019

BRIEF-Galapagos FY Revenue Up At 317.8 Million Euros

* SAID ON THURSDAY FY REVENUE EUR 317.8 MLN VS EUR 155.9 MLN YR AGO

22 Feb 2019

BRIEF-Galapagos And Fibrocor Sign Partnership Focusing On Fibrosis

* SAID ON FRIDAY FIBROCOR THERAPEUTICS L.P. AND GALAPAGOS SIGN PARTNERSHIP FOCUSING ON FIBROSIS

07 Jan 2019

Rheinmetall says in talks to buy stake in rival Krauss-Maffei

FRANKFURT Rheinmetall on Monday said it was in talks about buying a stake in rival KMW and Nexter Defense Systems N.V, sending shares in the defense company sharply higher.

26 Nov 2018

Rheinmetall says in talks to buy stake in rival Krauss-Maffei

FRANKFURT, Nov 26 Rheinmetall on Monday said it was in talks about buying a stake in rival KMW and Nexter Defense Systems N.V, sending shares in the defense company sharply higher.

26 Nov 2018

BRIEF-Galapagos Increases Share Capital Through Warrant Exercises

* ANNOUNCED ON FRIDAY A SHARE CAPITAL INCREASE ARISING FROM WARRANT EXERCISES

26 Nov 2018

BRIEF-Galapagos Reports Top-line Interim Results Of FALCON Trial Part 1 In CF

* REPORTED ON WEDNESDAY TOPLINE INTERIM RESULTS OF FALCON TRIAL PART 1 IN CF

25 Oct 2018

BRIEF-Galapagos 9-Month Revenue Rises To 205.1 Million Euros

* REPORTED ON WEDNESDAY 9-MONTH GROUP REVENUES INCREASED BY EUR 98.7 MILLION TO EUR 205.1 MILLION

25 Oct 2018

Earnings vs. Estimates